IL19 and breast carcinoma: Moreover, UALCAN was utilized to get the expression pattern of IL-19 in different subclasses and stages of breast cancer, and the results revealed that IL-19 is highly upregulated in the Luminal type of BC subtype, and the expression is upregulated in stage 3 of BC followed by stage 2.